Related Experiment Video
Updated: Mar 14, 2026
![Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F63025.jpg&w=3840&q=50)
Radiosynthesis of 1-2-[18F]Fluoroethyl-L-Tryptophan using a One-pot, Two-step Protocol
Published on: September 21, 2021
Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid
Elina Timosenko1, Hemza Ghadbane1, Jonathan D Silk1
1MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom.
Abstract:
Tryptophan degradation is an immune escape strategy shared by many tumors. However, cancer cells' compensatory mechanisms remain unclear. We demonstrate here that a shortage of tryptophan caused by expression of indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) resulted in ATF4-dependent upregulation of several amino acid transporters, including SLC1A5 and its truncated isoforms, which in turn enhanced tryptophan and glutamine uptake. Importantly, SLC1A5 failed to be upregulated in resting human T cells kept under low tryptophan conditions but was enhanced upon cognate antigen T-cell receptor engagement. Our results highlight key differences in the ability of tumor and T cells to adapt to tryptophan starvation and provide important insights into the poor prognosis of tumors coexpressing IDO and SLC1A5. Cancer Res; 76(21); 6193-204. ©2016 AACR.
Insights
Tumors use tryptophan degradation to evade immune responses. Cancer cells compensate by upregulating amino acid transporters, unlike T cells, indicating a poor prognosis for tumors expressing indoleamine 2,3-dioxygenase (IDO) and SLC1A5.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- Tryptophan degradation is a known tumor immune escape mechanism.
- The compensatory mechanisms of cancer cells facing tryptophan starvation are not fully understood.
Purpose of the Study:
- To investigate the adaptive responses of cancer cells and T cells to tryptophan deficiency.
- To elucidate the role of amino acid transporters in tumor immune evasion.
Main Methods:
- Analysis of tryptophan-degrading enzymes indoleamine 2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO).
- Assessment of ATF4-dependent upregulation of amino acid transporters, including SLC1A5 and its isoforms.
- Comparison of SLC1A5 regulation in tumor cells versus human T cells under varying tryptophan conditions.
Main Results:
- IDO and TDO expression led to ATF4-dependent upregulation of SLC1A5 and its isoforms, enhancing tryptophan and glutamine uptake in cancer cells.
- SLC1A5 upregulation was not observed in resting human T cells under low tryptophan conditions.
- T-cell receptor engagement enhanced SLC1A5 in T cells, suggesting differential regulation.
Conclusions:
- Tumor cells exhibit distinct adaptive mechanisms to tryptophan starvation compared to T cells.
- The coexpression of IDO and SLC1A5 in tumors is associated with a poor prognosis.
- Understanding these differences provides insights into cancer immune evasion strategies.
More Related Videos
11:51Engineering 'Golden' Fluorescence by Selective Pressure Incorporation of Non-canonical Amino Acids and Protein Analysis by Mass Spectrometry and Fluorescence
Published on: April 27, 2018
10:38Simultaneous Quantification of Selected Kynurenines Analyzed by Liquid Chromatography-Mass Spectrometry in Medium Collected from Cancer Cell Cultures
Published on: May 9, 2020
Related Concept Videos
Amino Acid Biosynthetic Pathways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Repressible Operon: trp Operon
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Stringent Response in E. coli